Polyoxometalate-cyclodextrin supramolecular entities for real-time in situ monitoring of dopamine released from neuroblastoma cells

by Saptami Suresh Shetty, Basem Moosa, Li Zhang, Buthainah Al-Shankitia, Walaa Baslyman, Veerappan Mani, Niveen M. Khashab, Khaled Nabil Salama
Year: 2023 DOI: 10.1016/j.bios.2023.115240

Bibliography

Shetty, S. S., Moosa, B., Zhang, L., Alshankiti, B., Baslyman, W., Mani, V., Khashab, N. M., & Salama, K. N. (2023). Polyoxometalate-cyclodextrin supramolecular entities for real-time in situ monitoring of dopamine released from neuroblastoma cells. Biosensors and Bioelectronics, 229, 115240.

Abstract

Optimized and sensitive biomarker detection has recently been shown to have a critical impact on quality of diagnosis and medical care options. In this research study, polyoxometalate-γ-cyclodextrin metal-organic framework (POM-γCD MOF) was utilized as an electrocatalyst to fabricate highly selective sensors to detect in-situ released dopamine. The POM-γCD MOF produced multiple modes of signals for dopamine including electrochemical, colorimetric, and smartphone read-outs. Real-time quantitative monitoring of SH-SY5Y neuroblastoma cellular dopamine production was successfully demonstrated under various stimuli at different time intervals. The POM-CD MOF sensor and linear regression model were used to develop a smartphone read-out platform, which converts dopamine visual signals to digital signals within a few seconds. Ultimately, POM-γCD MOFs can play a significant role in the diagnosis and treatment of various diseases that involve dopamine as a significant biomarker.